Obsidian Therapeutics, Inc. Common Stock (OBX) stock: key figures, P/E, revenue and dividend
Health Care · United States
Obsidian Therapeutics, Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -91.26 m USD | -105.67 m USD |
| EBIT | -91.26 m USD | -105.67 m USD |
| Net income | -83.11 m USD | -100.61 m USD |
| Diluted EPS – continuing operations | -1.35 USD | -1.63 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Obsidian Therapeutics, Inc. Common Stock
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.
More stocks
- Borr Drilling Ltd (BORR)
- MedCap AB (publ) (MCAP.ST)
- Hygeia Healthcare Holdings Co Ltd (6078.HK)
- Hite Jinro (000080.KS)
- N-able, Inc. (NABL)
- Zhongtong Bus Holding Co Ltd (000957.SZ)
- Beta Bionics, Inc. (BBNX)
- Synsam AB (publ) (SYNSAM.ST)
- Zhejiang Tongxing Technology Co. Ltd. A (301252.SZ)
- Shanghai Urban Architecture Design Co. Ltd. (300983.SZ)
- Rastar Group (300043.SZ)
- Daqo New Energy Corp (DQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.